Risk and benefit: the eternal Yin and Yang of thoracic surgery

Little, Alex G.
November 2007
Thorax;Nov2007, Vol. 62 Issue 11, p929
Academic Journal
The author reflects on the study which defines the specific risk factors and develops a helpful model to estimate the risk of postoperative death in patients with non-small cell lung cancer (NSCLC). He states that the findings highlight the importance of tracking patient outcomes in a prospective database. On the other hand, he stresses that the study should have emphasized the essential role of the quality and length of life in developing and recommending therapeutic strategies for NSCLC.


Related Articles

  • Obesity and therapy-related toxicity in patients treated for small-cell lung cancer. Georgiadis, Mark S.; Steinberg, Seth M. // JNCI: Journal of the National Cancer Institute;3/1/95, Vol. 87 Issue 5, p361 

    Reports on the absence of an association between obesity and increased treatment toxicity or decreased survival among patients with small-cell lung cancer. Study conducted in clinical trials; Use of standard body weight to calculate drug doses; Comparison of patient body mass index.

  • Second Primary Cancers Related to Smoking and Treatment of Small-Cell Lung Cancer. Tucker, Margaret A.; Murray, Nevin; Shaw, Edward G.; Ettinger, David S.; Mabry, Mack; Huber, Martin H.; Feld, Ronald; Shepherd, Frances A.; Johnson, David H.; Grant, Stefan C.; Aisner, Joseph; Johnson, Bruce E. // JNCI: Journal of the National Cancer Institute;12/03/97, Vol. 89 Issue 23, p1782 

    Presents information on a study on second primary cancers related to smoking and treatment of small-cell lung cancer. Methods; Results and discussion; Implications of the study.

  • The quality of life questionnaire for cancer patients treated with anticancer drugs (QOL-ACD): validity and reliability in japanese patients with advanced non-small-cell lung cancer. Matsumoto, T.; Ohashi, Y.; Morita, S.; Kobayashi, K.; Shibuya, M.; Yamaji, Y.; Eguchi, K.; Fukuoka, M.; Nagao, K.; Nishiwaki, Y.; Niitani, H.; CPT-11 Lung Cancer Study Groups West and East // Quality of Life Research;Aug2002, Vol. 11 Issue 5, p483 

    The quality of life questionnaire for cancer patients treated with anticancer drugs (QOL-ACD), which consists of four domains (functional, physical, mental, and psychosocial) and a global face scale, was developed as a generic questionnaire for Japanese cancer patients undergoing chemotherapy....

  • The health-related quality of life and survival of small-cell lung cancer patients: results of a companion study to CALGB 9033. Naughton, M.J.; Herndon II, J.E.; Shumaker, S.A.; Miller, A.A.; Kornblith, A.B.; Chao, D.; Holland, J.; Herndon, J E 2nd // Quality of Life Research;May2002, Vol. 11 Issue 3, p235 

    The purposes of this study were 2-fold: to evaluate the impact of the schedule dependency of etoposide (3-day IV short course vs. a 21-day oral prolonged course) with cisplatin on the quality of life of small-cell lung cancer (SCLC) patients; and to examine the effect of baseline quality of life...

  • Chimiothérapie du cancer bronchopulmonaire métastatique: critères de choix. Sablin, M.-P.; Domont, J.; Spano, J.-P.; Méric, J.-B. // Oncologie;oct2005, Vol. 7 Issue 6, p456 

    The therapeutic strategy of metastatic non-small cell lung cancer has greatly changed due to the availability of new chemotherapeutic regimens. Cisplatin based doublet regimen remains the standard treatment but new drug combinations are now available. Overall survival and response rates are...

  • A meta Analysis of Aidi Injection plus Taxotere and Cisplatin in the Treatment of Non-small Cell Lung Cancer. Quan Wang; Xiran He; Jinhui Tian; Xiaogang Wang; Peifan Ru; Ziliang Ruan; Kehu Yang // Chinese Journal of Lung Cancer;Nov2010, Vol. 13 Issue 11, p1027 

    Background and objective Compared with chemotherapy, whether aidi injection can improve the patient's quality of life is not definite. The aim of this study is to evaluate the efficacy and safety of axotere plus eisplatin chemotherapy combining aidi injection for patients with non-small cell...

  • The Study of Therapy with Paclitaxel: Based on a Case of Therapy with Paclitaxel. Fujita, Yoshitsugu; Mineshita, Masamichi; Handa, Hiroshi; Oshige, Masahiro; Nishine, Ami; Miyazawa, Teruomi; Seki, Nobuhiko; Eguchi, Kenji; Inoue, Ken // International Medical Journal;Jun2010, Vol. 17 Issue 2, p153 

    The article presents a case study of a 70-year old male diagnosed with small cell lung cancer (SCLC) and have undergone a total of 4 courses of carboplatin and irinotecan. His medical screening indicated an abnormal shadows on a chest x-ray and was referred to a hospital due to a suspected lung...

  • Quality of life assessment as a predictor of survival in non-small cell lung cancer.  // BMC Cancer;2011, Vol. 11 Issue 1, p353 

    The article offers information on a research conducted on the assessment of quality of life as a predictor of survival in non-small cell lung cancer, in the U.S. It states that the primary end point was the patient survival, which was defined as the time interval between the patient's first...

  • Women at double risk of small cell lung cancer. Kmietowicz, Zosia // BMJ: British Medical Journal (International Edition);12/12/98, Vol. 317 Issue 7173, p1614 

    Reports on the increased possibility of developing small cell lung cancer in women. Clinical features of patients with lung cancer in several hospitals in Great Britain; Particular age of women who are at risk of small cell lung cancer as compared with men; Reasons for the differences between...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics